Benchmark’s commercial restructures enhance the total salmon portfolio 

The newly appointed Commercial Director, Kate F. Stenerud, surrounded by her team in Bergen in June this year.

As from 1 February this year, Benchmark has implemented commercial restructures to its Genetics and Health business areas

Unifying the sales team for salmon products, the company has further solidified its commitment to delivering excellence and strengthen customer relationships. Kate Furhovden Stenerud has been appointed as the new Commercial Director for salmon, bringing her expertise to drive growth. The UK-based team, comprising Ben Perry, Harry Tziouvas, and Andrew Preston, stand ready to leverage their comprehensive knowledge to serve both local and global customers with the complete product portfolio of genetics and sea lice medicines.

Find out more: